Literature DB >> 29856490

SIRT1 inhibits TGF-β-induced endothelial-mesenchymal transition in human endothelial cells with Smad4 deacetylation.

Zhen Li1, Fei Wang1, Siyuan Zha1, Qing Cao1, Jing Sheng2, Shuyan Chen1.   

Abstract

Endothelial-mesenchymal transition (EndMT) plays a pivotal role in organ fibrosis. This study examined the effect of SIRT1 on transforming growth factor beta (TGF-β)-induced EndMT in human endothelial cells (ECs) and its probable molecular mechanism. We assessed EndMT by immunofluorescence staining, quantitative real-time polymerase chain reaction, Western blotting, and migration and invasion assays. Adenovirus was used to overexpress or knockdown SIRT1 in ECs. The regulatory relationship between SIRT1 and Smad4 was analyzed by coimmunoprecipitation assay. We found that SIRT1 was decreased in TGF-β-induced EndMT, and SIRT1 inhibited TGF-β-induced EndMT through deacetylating Smad4. Our findings suggest that SIRT1 has an important role in inhibiting EndMT by regulating the TGF-β/Smad4 pathway in human ECs and, thus, protecting against fibrosis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  SIRT1; Smad4; TGF-β; endothelial-mesenchymal transition (EndMT); fibrosis

Mesh:

Substances:

Year:  2018        PMID: 29856490     DOI: 10.1002/jcp.26846

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 2.  Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases.

Authors:  Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

3.  Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation.

Authors:  Vera Miranda-Gonçalves; Ana Lameirinhas; Catarina Macedo-Silva; João Lobo; Paula C Dias; Verónica Ferreira; Rui Henrique; Carmen Jerónimo
Journal:  Cells       Date:  2020-04-23       Impact factor: 6.600

4.  PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity.

Authors:  Siyuan Zha; Zhen Li; Qing Cao; Fei Wang; Fang Liu
Journal:  Stem Cell Res Ther       Date:  2018-08-23       Impact factor: 6.832

Review 5.  The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1.

Authors:  Jolien Fledderus; Byambasuren Vanchin; Marianne G Rots; Guido Krenning
Journal:  J Pers Med       Date:  2021-02-05

Review 6.  SMAD4 contributes to chondrocyte and osteocyte development.

Authors:  Katayoon Pakravan; Ehsan Razmara; Bashdar Mahmud Hussen; Fatemeh Sattarikia; Majid Sadeghizadeh; Sadegh Babashah
Journal:  J Cell Mol Med       Date:  2021-11-28       Impact factor: 5.310

Review 7.  A promising field: regulating imbalance of EndMT in cardiovascular diseases.

Authors:  Kun Zhou; Kai-Jiang Tian; Bin-Jie Yan; Dan-Dan Gui; Wen Luo; Zhong Ren; Dang-Heng Wei; Lu-Shan Liu; Zhi-Sheng Jiang
Journal:  Cell Cycle       Date:  2021-07-16       Impact factor: 5.173

8.  Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter.

Authors:  Shuai Song; Rui Zhang; Wei Cao; Guojian Fang; Yi Yu; Yi Wan; Chuanhui Wang; Yigang Li; Qunshan Wang
Journal:  J Cell Physiol       Date:  2018-10-30       Impact factor: 6.384

9.  TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells.

Authors:  Cyril Corbet; Estelle Bastien; Joao Pedro Santiago de Jesus; Emeline Dierge; Ruben Martherus; Catherine Vander Linden; Bastien Doix; Charline Degavre; Céline Guilbaud; Laurenne Petit; Carine Michiels; Chantal Dessy; Yvan Larondelle; Olivier Feron
Journal:  Nat Commun       Date:  2020-01-23       Impact factor: 14.919

Review 10.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.